Quality control testing of pharmaceuticals must be rigorous: impurities can take many forms, from solids to volatiles and everything in between.
VELP has engineered the innovative EMA 502 to offer solutions for pharma laboratories conducting tests on small molecule impurities. VELP’s new all-in-one solution for simultaneous CHNS-O quantitative determination delivers the best outcomes with the highest possible convenience.
High-performance, unsupervised operation, low maintenance, and cloud connection to VELP Ermes Platform enable laboratories to assure the behavior and confirm the purity of pharmaceutical drugs, as well as to maintain and control the quality at every stage of the new product development, manufacturing and commercialization.
Do you need to perform your analysis in accordance with international standards? The EMA 502 features the additional 21 CFR Part 11 Package to achieve full compliance with regulations.
Join our specialist to discover how just one easy-to-use and powerful instrument, equipped with the most advanced technologies, enables you to successfully face multiple analytical challenges in pharmaceutical manufacturing, where precision remains critical.